Review
doi: 10.1016/j.hoc.2005.05.010.
Treatment-related neurotoxicity
Affiliations
- PMID: 16083833
- DOI: 10.1016/j.hoc.2005.05.010
Item in Clipboard
Review
Treatment-related neurotoxicity
Hematol Oncol Clin North Am.
2005 Aug.
Abstract
Two challenges need to be addressed to improve the outcome of patients with primary central nervous system lymphoma. The first challenge is to develop therapies that result in less toxicity and improved long-term outcome. The second challenge is to develop interventions to help those patients who develop treatment-related neurotoxicity; ongoing collaborative efforts are required to improve communication and understanding of this complication. Long-term follow up of prospective therapeutic studies should report on both disease control and the development of neurotoxicity. New protocols should include prospective longitudinal measures of neurocognitive function.
Similar articles
-
Preliminary results of combined chemotherapy and radiotherapy for non-AIDS primary central nervous system lymphoma. Trans-Tasman Radiation Oncology Group (TROG).Med J Aust. 1996 Oct 21;165(8):424-7. Med J Aust. 1996. PMID: 8913243 Clinical Trial.
-
Combined-modality therapy for primary central nervous system lymphoma: long-term data from a Phase II multicenter study (Trans-Tasman Radiation Oncology Group).Int J Radiat Oncol Biol Phys. 2006 Feb 1;64(2):408-13. doi: 10.1016/j.ijrobp.2005.07.958. Epub 2005 Sep 28. Int J Radiat Oncol Biol Phys. 2006. PMID: 16198065 Clinical Trial.
-
Long-term follow-up of high-dose methotrexate-based therapy with and without whole brain irradiation for newly diagnosed primary CNS lymphoma.J Clin Oncol. 2006 Oct 1;24(28):4570-4. doi: 10.1200/JCO.2006.06.6910. J Clin Oncol. 2006. PMID: 17008697
-
[Treatment of primary central nervous system lymphoma in the immunocompetent patient].Rev Neurol (Paris). 2008 Jun-Jul;164(6-7):569-74. doi: 10.1016/j.neurol.2008.04.001. Epub 2008 May 21. Rev Neurol (Paris). 2008. PMID: 18565356 Review. French.
-
[Treatment of central nervous system malignant lymphoma].No To Shinkei. 2005 Dec;57(12):1043-9. No To Shinkei. 2005. PMID: 16375189 Review. Japanese. No abstract available.
Cited by
-
Comparison of oxaliplatin- and cisplatin-induced painful peripheral neuropathy in the rat.J Pain. 2009 May;10(5):534-41. doi: 10.1016/j.jpain.2008.12.003. Epub 2009 Feb 23. J Pain. 2009. PMID: 19231296 Free PMC article.
-
O6-methylguanine-DNA methyltransferase (MGMT) immunohistochemistry as a predictor of resistance to temozolomide in primary CNS lymphoma.J Neurooncol. 2013 Aug;114(1):135-40. doi: 10.1007/s11060-013-1162-y. Epub 2013 May 18. J Neurooncol. 2013. PMID: 23686298 Clinical Trial.
-
Changes in neurocognitive functioning and quality of life in adult patients with brain tumors treated with radiotherapy.J Neurooncol. 2012 Jun;108(2):291-308. doi: 10.1007/s11060-012-0821-8. Epub 2012 Feb 18. J Neurooncol. 2012. PMID: 22354791 Review.
-
Survival among patients with primary central nervous system lymphoma, 1973-2004.J Neurooncol. 2011 Feb;101(3):487-93. doi: 10.1007/s11060-010-0269-7. Epub 2010 Jun 17. J Neurooncol. 2011. PMID: 20556477
-
Primary CNS Lymphomas: Challenges in Diagnosis and Monitoring.Biomed Res Int. 2018 Jun 21;2018:3606970. doi: 10.1155/2018/3606970. eCollection 2018. Biomed Res Int. 2018. PMID: 30035121 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
